The vaping cessation pill, varenicline, has emerged as a groundbreaking solution for those struggling with nicotine addiction, particularly among adolescents.Recently, a significant clinical trial showcased that young adults aged 16 to 25 who used this FDA-approved smoking cessation pill were over three times more successful in quitting vaping compared to those on placebo.